Physostigmine antagonizes benzodiazepine-induced myoclonus in the baboon, Papio papio.
The antagonism of some benzodiazepine (Bz) actions by physostigmine was investigated in 4 Papio papio baboons. As a model of these actions, the myoclonus induced in this species by clonazepam i.m. administration was used. The baboon develops, 20-30 min after Bz i.m. injection, a non-epileptic myoclonus characterized by clinical symptomatology (jerks involving mainly the neck and the trunk bilaterally), by the absence of any correlative EEG discharge, and by its facilitation during movement. This Bz-induced myoclonus resembles the intention myoclonus of human patients, as seen for example after anoxia. In the present series, the effect of physostigmine i.v. injection on the frequency of clonazepam-induced myoclonus was tested. Physostigmine produces a rapid and total abolition of the myoclonus, and this effect lasts for a period which corresponds to the pharmacological activity of physostigmine. On the contrary, atropine i.v. injection considerably increases the amount of Bz-induced myoclonus. These results allow the existence of an anticholinergic action of benzodiazepines, reversed by physostigmine, and the theory that the myoclonus would be the consequence of a cholinergic system depression to be hypothesized.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001570:Benzodiazepinones / Q000037:antagonists & inhibitors*; D002998:Clonazepam / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D004357:Drug Synergism; D009207:Myoclonus / Q000139:chemically induced*; D010215:Papio; D010276:Parasympatholytics; D010830:Physostigmine / Q000494:pharmacology*
D001570:Benzodiazepinones; D010276:Parasympatholytics; D002998:Clonazepam; D001285:Atropine; D010830:Physostigmine